AMANDA ROBALIN: Open Payments
NPI 1598220691 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 114 payments from 18 companies in 2025. Trend: 2023 $2,569 · 2024 $2,055 · 2025 $2,190
Food & beverage: $2,000Education: $190
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $280 |
| Janssen Biotech, Inc. | 20 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $229 |
| ABBVIE INC. | 18 | $226 |
| Arcutis Biotherapeutics, Inc. | 11 | $211 |
| E.R. Squibb & Sons, L.L.C. | 12 | $196 |
| Almirall LLC | 6 | $160 |
| Incyte Corporation | 4 | $111 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $106 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: Bimzelx, TREMFYA, DUPIXENT, Zoryve, Sotyktu, Seysara, SKYRIZI, OPZELURA.
Industry payments across TX — which companies pay providers there.
